Celltrion Covid
Scope
Date
~
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Airlines
Korea-China air flights set to rise with Beijing’s eased zero-COVID policy
Air flights between South Korea and China are set to rise significantly next year with the Chinese government issuing new guidelines easing its stri...
Dec 22, 2022 (Gmt+09:00)
-
Bio & Pharma
HLB Therapeutics signs contract for COVID vaccine distribution rights
South Korea's pharmaceutical firm HLB Therapeutics Co. said on Monday that it has signed an agreement with the Korea Disease Control and Prevention ...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Seegene's COVID-19 diagnostic product wins Product of the Year Award
Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum ...
Dec 16, 2022 (Gmt+09:00)
-
Perspectives
China’s COVID reopening poses risks and opportunities
News that Beijing is finally scrapping its growth-killing “zero COVID” policy seems the equivalent of answered prayers for Asia. And it co...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's 2021 bio sector output $15.4 bn; 5-year annual growth 20%
South Korea's bio industry last year exceeded 20 trillion won ($15.4 billion) in production for the first time and continues to see strong growth.Th...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
PCL’s diagnostic kit measures concentration of COVID-19 antibodies
PCL Inc., a South Korean in vitro diagnostics device maker, plans to bring two test kits – one that simultaneously detects COVID-19 and influenza infe...
Dec 08, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion to seek FDA approval for sale of Remsima SC by year-end
Celltrion Inc. said it has confirmed the effectiveness and safety of Remsima SC in its third-phase global clinical trials, conducted on 438 patients...
Nov 28, 2022 (Gmt+09:00)
-
Travel & Leisure
MZers drive Korea's indoor golf facility pandemic boom
Indoor golf facilities’ revenue in South Korea has skyrocketed amid the pandemic, thanks to millennials and Generation Zers' soaring consumpti...
Nov 21, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins trial against Regeneron for US patent lawsuit over biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...
Nov 18, 2022 (Gmt+09:00)
-
Airlines
S. Korea's T'way Air to resume Incheon-Chiang Mai route
South Korea's budget carrier T'way Air on Wednesday said it will resume from Nov. 28 its flight linking Incheon and Chiang Mai, Thailand, with seven...
Nov 17, 2022 (Gmt+09:00)
-
Earnings
Celltrion's Q3 earnings boosted by Remsima sales in Europe
South Korean biopharmaceutical giant Celltrion Inc. announced 654.6 billion won ($478.2 million) in revenue and 213.8 billion won in operating profi...
Nov 09, 2022 (Gmt+09:00)
-
Earnings
Korea's Walkerhill Hotels and Resorts posts 1st surplus in 11 quarters
South Korea's Walkerhill Hotels and Resorts, run by SK Networks, has returned to the black after two years and nine months thanks to growth in the n...
Nov 09, 2022 (Gmt+09:00)
-
Korean stock market
Rising interest rates reshuffle Korean market cap list
Rising interest rates amid a slowing global economy rattled South Korean companies’ market capitalization rankings, bumping online players suc...
Oct 28, 2022 (Gmt+09:00)
-
Healthcare
Celltrion targets digital healthcare sector with app
Celltrion Inc., South Korea’s biopharmaceutical giant, made a foray into the digital healthcare sector for its future growth by launching a sm...
Oct 05, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins sales approval for biosimilar Vegzelma in Japan
Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...
Sep 27, 2022 (Gmt+09:00)
-
COVID-19
SK Bioscience seeks WHO nod for prompt COVID vaccine sale
SK Bioscience Co., the biopharmaceutical unit of South Korea’s No. 2 conglomerate SK Group, sought approval from the World Health Organization...
Sep 08, 2022 (Gmt+09:00)
-
Airlines
Korea airlines to increase flights on eased COVID-19 rule
South Korean airlines plan to increase international flights by year-end as the country is set to ease the rule on COVID-19 for travelers in a move ...
Aug 31, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion gains sales approval for biosimilar Vegzelma in Europe
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...
Aug 19, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's SD Biosensor to supply diagnostics kits to Japan in H2
SD Biosensor Inc., South Korea’s leading in-vitro diagnostics company, has signed an agreement to supply its COVID-19 self-test kits and other...
Aug 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare logs record-high Q2 revenue on back of Remsima
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.’s global marketing affiliate, posted its record-high second-quar...
Aug 17, 2022 (Gmt+09:00)
-
Korean food
K-chicken chain BB.Q foresees stores quadrupling in N.America
Gourmands in North America will be able to enjoy South Korean fried chicken more conveniently as BB.Q Chicken, the country’s leading franchise...
Aug 15, 2022 (Gmt+09:00)
-
Earnings
Celltrion logs strong Q2 earnings powered by biosimilars
South Korea’s biopharmaceutical maker Celltrion Inc. on Friday reported strong quarterly earnings thanks to healthy demand for its biosimilar ...
Aug 05, 2022 (Gmt+09:00)
-
Real estate
Development will outperform in post-COVID era: Principal Real Estate
Real estate is in the global investor spotlight amid skyrocketing inflation. However, not all property sectors or locations will offer the same infl...
Jul 22, 2022 (Gmt+09:00)
-
COVID-19
Ildong mulls seeking COVID-19 pill approval from Korea first
Ildong Pharmaceutical Co., a South Korean drugmaker, considers seeking approval for a COVID-19 anti-viral pill from the country as Japan postponed g...
Jul 22, 2022 (Gmt+09:00)
-
Airlines
Korean LCCs’ international flight recovery remains slow
South Korean budget airlines are seeing a slow recovery in international flights as key routes such as China and Japan have yet to normalize while t...
Jul 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Samsung Biologics eye record-high annual sales
South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...
Jul 08, 2022 (Gmt+09:00)
-
Batteries
LG Energy surrenders No. 2 EV battery position to BYD
LG Energy Solution Ltd., South Korea’s leading battery maker, gave up its second-largest position in the global electric vehicle cell market...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience wins marketing license for Korea's first COVID-19 vaccine
South Korea’s SK Bioscience Co., a biopharmaceutical unit of SK Group, has won marketing authorization for its COVID-19 vaccine from the Minis...
Jun 29, 2022 (Gmt+09:00)
language